AxoGen to Present at JMP Securities Healthcare Conference 2016
June 16 2016 - 7:00AM
AxoGen, Inc. (NASDAQ:AXGN), a leader in developing and marketing
innovative surgical solutions for peripheral nerve injuries, today
announced that Peter J. Mariani, Chief Financial Officer, will
present at JMP Securities Healthcare Conference 2016 in New York
City at the St. Regis Hotel. The presentation is scheduled for
Tuesday, June 21, 2016 at 3:30 pm ET (12:30 pm PT).
The presentation will be webcast live and can be
accessed through the Investors page at www.axogeninc.com. For those
not available to listen to the live broadcast, a replay will be
archived for 90 days and available through the Investors page on
www.axogeninc.com.
About AxoGen
AxoGen (AXGN) is a leading medical technology
company dedicated to peripheral nerve repair. AxoGen's portfolio of
regenerative medicine products is available in the United States,
Canada and several other countries and includes Avance® Nerve
Graft, an off-the-shelf processed human nerve allograft for
bridging severed nerves without the comorbidities associated with a
second surgical site, AxoGuard® Nerve Connector, a porcine
submucosa extracellular matrix ("ECM") coaptation aid for
tensionless repair of severed nerves, and AxoGuard® Nerve
Protector, a porcine submucosa ECM product used to wrap and protect
injured peripheral nerves and reinforce the nerve reconstruction
while preventing soft tissue attachments. Along with these core
surgical products, AxoGen also offers AxoTouchTM Two-Point
Discriminator and AcroValTM Neurosensory & Motor Testing
System. These evaluation and measurement tools assist healthcare
professionals in detecting changes in sensation, assessing return
of sensory, grip and pinch function, evaluating effective treatment
interventions, and providing feedback to patients on nerve
function.
Contacts:
AxoGen, Inc.
Peter J. Mariani, Chief Financial Officer
386.462.6856
InvestorRelations@AxoGenInc.com
The Trout Group – Investor Relations
Brian Korb
646.378.2923
bkorb@troutgroup.com
Axogen (NASDAQ:AXGN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Axogen (NASDAQ:AXGN)
Historical Stock Chart
From Apr 2023 to Apr 2024